ici 204,219 has been researched along with Lung Diseases, Interstitial in 2 studies
zafirlukast: a leukotriene D4 receptor antagonist
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chohnabayashi, N | 1 |
| Sugiura, R | 1 |
| Nishimura, N | 1 |
| Wechsler, ME | 1 |
| Garpestad, E | 1 |
| Flier, SR | 1 |
| Kocher, O | 1 |
| Weiland, DA | 1 |
| Polito, AJ | 1 |
| Klinek, MM | 1 |
| Bigby, TD | 1 |
| Wong, GA | 1 |
| Helmers, RA | 1 |
| Drazen, JM | 1 |
1 review available for ici 204,219 and Lung Diseases, Interstitial
| Article | Year |
|---|---|
[Adverse effects of leukotriene-antagonists].
Topics: Acetates; Anaphylaxis; Chemical and Drug Induced Liver Injury; Chromones; Cyclopropanes; Drug Intera | 2007 |
1 other study available for ici 204,219 and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast.
Topics: Adult; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Cardiomyopathies; Churg-Strauss Synd | 1998 |